Skip to content

Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue(CRF)

Randomized, Double-Blind, Placebo-Controlled, Stage II Trial of Acupuncture For Lung Cancer Patients With Cancer Related Fatigue(CRF)

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01881516
Enrollment
32
Registered
2013-06-19
Start date
2013-07-31
Completion date
Unknown
Last updated
2013-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Related Fatigue, Lung Cancer

Brief summary

we plan to conduct this trial to find out: * If acpuncture treatment could relieve CRF among lung cancer patients receiving chemo- or radio-therapy? * How about the extent it relieves?the safety and applicability ? * What's the possible influential factor and mechanism ?

Interventions

DEVICEacupuncture

once per week for 6 weeks,30 mins for each treatment and for seven main acupoints

DEVICEsham acupuncture

the same acupoints and time as in acupuncture arm, but use a Park Sham Device

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are pathologically/cytologically diagnosed as NSCLC and received radiotherapy with or without chemotherapy, and the last radio- or chemo-therapy must be at least 30 days prior to initiation of experimental treatment; * Participants who meet the diagnosis criteria of CRF(ICD-10 criteria); * The first time to receive acupuncture treatment; * The age is between 18 and 65 years old; * Mean baseline fatigue as measured by the Brief Fatigue Inventory (BFI) must be four or above; * ECOG performance status 0, 1 or 2. * Patients must have adequate organ functions reflected by the laboratory criteria below: neutrophil counts ≥ 1.5×109 /L, platelet count ≥ 100 x 109/L, hemoglobin ≥ 85 g/L, Serum creatinine \< 2.0 mg/dL, Bilirubin \< 1.5 mg/dL, ALT \< 3 x normal, albumin \>30g/L. * Have not taken any hypnotic, melatonin, or antidepressants within 30 days; * Willing to finish the whole observation period; * With written consent form signed by themselves.

Exclusion criteria

* Participants in other clinical research; * Can not be pathologically or cytologically diagnosed as NSCLC; * ECOG 3\ 4; * Pregnant woman; * \>65 or \<18 years old; * Patients with evidence of any cognitive dysfunction that would limit their abilities to report fatigue; * Patients who have received acupuncture ever before; * Received surgery, immunotherapy or target therapy within one month before the recruition; * Taking warfarin or heparin, a bleeding tendency exists; * Infection, ulceration or hyperalgesia at or near the local acupoints' skin,or with active infections; * There are cerebral vascular accident history or spinal cord injury history; * Combination with other serious diseases or condition, including congestive heart failure, Unstable angina pectoris, myocardial infarction during the past six months, serious's arrhythmia, mental disorders, drug abuse, etc.; * Patients with a life expectancy \< 3 months; * Patients with a past history of therapy or scheduled visits non-compliance, as determined by their treating physician.

Design outcomes

Primary

MeasureTime frame
Brief Fatigue Inventory, BFI12 months

Secondary

MeasureTime frame
MDASI-C12 months
number of adverse events of acupuncture24 months
FACT-L12 months

Contacts

Primary Contactjing xie, MD
isable624@163.com+86 021 64175590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026